Zur Kurzanzeige

dc.creatorZachou K., Arvaniti P., Azariadis K., Lygoura V., Gatselis N.K., Lyberopoulou A., Koukoulis G.K., Dalekos G.N.en
dc.date.accessioned2023-01-31T11:38:04Z
dc.date.available2023-01-31T11:38:04Z
dc.date.issued2019
dc.identifier10.1111/hepr.13252
dc.identifier.issn13866346
dc.identifier.urihttp://hdl.handle.net/11615/80917
dc.description.abstract[No abstract available]en
dc.language.isoenen
dc.sourceHepatology Researchen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85055257446&doi=10.1111%2fhepr.13252&partnerID=40&md5=011764729ba04ee66cce81d15c7c30b4
dc.subjectalkaline phosphataseen
dc.subjectaminotransferaseen
dc.subjectantinuclear antibodyen
dc.subjectaspartate aminotransferaseen
dc.subjectazathioprineen
dc.subjectbilirubinen
dc.subjectcorticosteroiden
dc.subjectgamma glutamyltransferaseen
dc.subjectimmunoglobulin Gen
dc.subjectmethylprednisoloneen
dc.subjectmycophenolate mofetilen
dc.subjectprednisoloneen
dc.subjectsmooth muscle antibodyen
dc.subjectacute severe autoimmune hepatitisen
dc.subjectacute severe autoimmune hepatitisen
dc.subjectadolescenten
dc.subjectadulten
dc.subjectageden
dc.subjectArticleen
dc.subjectautoimmune hepatitisen
dc.subjectdisease exacerbationen
dc.subjectdrug dose increaseen
dc.subjectdrug dose reductionen
dc.subjectdrug megadoseen
dc.subjectdrug withdrawalen
dc.subjectenzyme linked immunosorbent assayen
dc.subjectfemaleen
dc.subjectfibrosisen
dc.subjectfollow upen
dc.subjecthumanen
dc.subjectimmune responseen
dc.subjectimmunofluorescenceen
dc.subjectimmunosuppressive treatmenten
dc.subjectinternational normalized ratioen
dc.subjectliver biopsyen
dc.subjectliver cirrhosisen
dc.subjectliver failureen
dc.subjectliver histologyen
dc.subjectmajor clinical studyen
dc.subjectmaleen
dc.subjectModel For End Stage Liver Disease Scoreen
dc.subjectobservational studyen
dc.subjectopen studyen
dc.subjectoverall survivalen
dc.subjectpolymerase chain reactionen
dc.subjectpriority journalen
dc.subjectrelapseen
dc.subjectremissionen
dc.subjectretrospective studyen
dc.subjectsepsisen
dc.subjecttreatment outcomeen
dc.subjecttreatment responseen
dc.subjectBlackwell Publishing Ltden
dc.titlePrompt initiation of high-dose i.v. corticosteroids seems to prevent progression to liver failure in patients with original acute severe autoimmune hepatitisen
dc.typejournalArticleen


Dateien zu dieser Ressource

DateienGrößeFormatAnzeige

Zu diesem Dokument gibt es keine Dateien.

Das Dokument erscheint in:

Zur Kurzanzeige